Annemieke Aartmsa-Rus, Ph.D., a first-time presenter at PPMD’s Annual Connect Conference last month, dissects topics like read through, gene therapy, cell therapy, and pharmaceutical therapies in an effort to explain the latest research strategies in Duchenne.